Meta-analysis of 31 cohort studies (≥32,134 people with systemic sclerosis): overall cancer risk was raised (SIR 1.66, 95% CI 1.32–2.08), highest for oesophageal, liver, cervical, lung and blood cancers; breast cancer not significant. Mean 7.4 years from SSc to cancer.
Meta-analysisn = 32,134
Teoh et al. Incidence of malignancy in systemic sclerosis: A systematic review and meta-analysis